Androgenetic Alopecia: Identification of Four Genetic Risk Loci and Evidence for the Contribution of WNT Signaling to Its Etiology

June 2013 in “ Faculty of Health; Institute of Health and Biomedical Innovation ”

Stefanie Heilmann, Amy K. Kiefer, Nadine Fricker, Dmitriy Drichel, Axel M. Hillmer, Christine Herold, Joyce Y. Tung, Nicholas Eriksson, Silke Redler, Regina C. Betz, Rui Li, Ari Karason, Dale R. Nyholt, Kijoung Song, Sita H. Vermeulen, Stavroula Kanoni, George Dedoussis, Nicholas G. Martin, Lambertus A. Kiemeney, Vincent Mooser, Kari Stefansson, J. Brent Richards, Tim Becker, Felix F. Brockschmidt, David A. Hinds, Markus M. Nöthen

androgenetic alopecia male-pattern baldness single-nucleotide polymorphisms SNPs genomic loci WNT signaling WNT10A hair follicle chromosomes genetic risk loci AGA baldness genes WNT

TLDR Four genetic risk areas related to male-pattern baldness were identified, with WNT signaling playing a role in its development.

In 2013, a study was conducted to identify unknown risk loci for androgenetic alopecia (AGA), also known as male-pattern baldness. The study replicated single-nucleotide polymorphisms (SNPs) at 12 genomic loci that showed suggestive association with AGA in a previous meta-analysis. The replication set comprised 2,759 cases and 2,661 controls of European descent. The combined analysis of the replication and the meta-analysis data identified four genome-wide significant risk loci for AGA on chromosomes 2q35, 3q25.1, 5q33.3, and 12p12.1. The strongest association signal was obtained for rs7349332 on chr2q35, located intronically in WNT10A. Expression studies in human hair follicle tissue suggested that WNT10A has a functional role in AGA etiology, providing genetic evidence supporting an involvement of WNT signaling in AGA development.

View this study on eprints.qut.edu.au →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community Evidenced Based Meta-Analyses and Systemic Reviews of Androgenic Alopecia and Treatments

in Research/Science 15 upvotes 4 years ago

Evidence-based treatments for androgenic alopecia, such as minoxidil, finasteride, low-level laser light therapy, dutasteride, platelet-rich plasma, and topical ketoconazole. It discusses the efficacy, safety, and mechanism of action of these treatments, as well as future developments in understanding this polygenic condition.

community CRISPR Is Curing People Right Now. Genetic Hair Loss is Next?

in Technology 107 upvotes 1 month ago

CRISPR shows promise for treating hair loss by targeting specific genes. Current treatments include Minoxidil and finasteride, but CRISPR could offer a more precise solution, though it is still expensive and in early stages.

community The Finasteride Shed is real.

in Finasteride/Dutasteride 159 upvotes 2 months ago

Increasing finasteride dosage can cause significant hair shedding initially. Users suggest adding minoxidil or switching to dutasteride for better results.

community What else is good. Besides the big 3.

in Chat 36 upvotes 1 month ago

Key treatments for hair preservation include minoxidil, finasteride/dutasteride, and microneedling, with additional options like specific shampoos, oils, biotin, zinc, tretinoin, clascoterone, and low-level laser therapy. Maintaining a healthy lifestyle, reducing stress, and addressing nutrient deficiencies can also support hair health.

community I have a hard time believing that creatine overpowers fin/dut

in Finasteride/Dutasteride 109 upvotes 1 year ago

The conversation is about whether creatine causes hair loss in individuals who are taking finasteride or dutasteride for hair loss. Some users report experiencing hair loss when taking creatine, while others do not. There is no consensus on the issue.

community Diffuse hair loss and scalp biopsies

in Research 692 upvotes 3 months ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

Similar Research

6 / 1000+ results

research Prediction of Male-Pattern Baldness from Genotypes

37 citations, October 2015 in “European Journal of Human Genetics”

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

SNP Variation in Male Pattern Hair Loss in Russians with Different Dihydrotestosterone Levels

research Androgenetic Alopecia: Update on Etiology

1 citations, March 2021 in “Dermatological reviews”

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.